Clinical Trials Browser

Unknown × Solid Tumor × pembrolizumab × Clear all

NCT04866485 2021-04-29

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Phase 1 Unknown

Other solid neoplasm

Solid Tumor